Association of the Aggrecan Keratan Sulfate-rich Region with Collagen in Bovine Articular Cartilage*

Håkan HedlundDagger §, Erik Hedbom, Dick Heinegårdparallel , Silwa Mengarelli-Widholm**, Finn P. Reinholt***, and Olle SvenssonDagger

From the Departments of Dagger  Orthopedics, ** Pathology, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Huddinge, Sweden, *** Pathology, University of Oslo, National Hospital, NO-0027 Oslo, Norway, the  Department of Rheumatology, University Hospital Zürich, CH-8091 Zürich, Switzerland, and the parallel  Department of Cell and Molecular Biology, University of Lund, SE-22100 Lund, Sweden

    ABSTRACT
Top
Abstract
Introduction
References

Aggrecan, the predominant large proteoglycan of cartilage, is a multidomain macromolecule with each domain contributing specific functional properties. One of the domains contains the majority of the keratan sulfate (KS) chain substituents and a protein segment with a proline-rich hexapeptide repeat sequence. The function of this domain is unknown but the primary structure suggests a potential for binding to collagen fibrils. We have examined binding of aggrecan fragments encompassing the KS-rich region in a solid-phase assay. A moderate affinity (apparent Kd = 1.1 µM) for isolated collagen II, as well as collagen I, was demonstrated. Enzymatic digestion of the KS chains did not alter the capacity of the peptide to bind to collagen, whereas cleavage of the protein core abolished the interaction. The distribution of the aggrecan KS-rich region in bovine tarsometatarsal joint cartilage was investigated using immunoelectron microscopy. Immunoreactivity was relatively low in the superficial zone and higher in the intermediate and deep zones of the uncalcified cartilage. Within the pericellular and territorial matrix compartments the epitopes representing the aggrecan KS-rich region were detected preferentially near or at collagen fibrils. Along the fibrils, epitope reactivity was non-randomly distributed, showing preference for the gap region within the D-period. Our data suggest that collagen fibrils interact with the KS-rich regions of several aggrecan monomers aligned within a proteoglycan aggregate. The fibril could therefore serve as a backbone in at least some of the aggrecan complexes.

    INTRODUCTION
Top
Abstract
Introduction
References

Articular cartilage matrix can be regarded as a fiber-reinforced composite material (1), where aggrecan complexes are entangled within a network of collagen fibrils. The aggrecan complexes, constituting about 90% of the proteoglycan content (2), endow the matrix with high osmotic pressure, compressive stiffness, and resilience, whereas collagen is essential for the tensile strength of the tissue (3). Different mechanical properties of the composite depend on these major constituents and how they are assembled and stabilized by intermolecular interactions. The capacity of cartilage to withstand mechanical stress depends upon its structural integrity and, hence, numerous interactions between the matrix components. Indeed, the molecules are so tightly associated that most of the tissue constituents require denaturing solvents or proteases for extraction. This has hampered studies of molecular function. To gain insight into the physiology of articular cartilage, it is necessary to identify and characterize interactions between the matrix constituents, particularly those involving the collagen.

In the present study we focused on a domain of the aggrecan molecule containing the majority of the keratan sulfate (KS)1 chain substituents and a protein segment with a hexapeptide repeat sequence (4). The second globular domain (G2) is localized adjacent to this KS-rich region, on the N-terminal side. The first globular domain (G1), which represents the hyaluronan-binding region (HABr), is localized next to G2 as the very N-terminal portion of aggrecan. On the C-terminal side of the KS-rich region, there is a large chondroitin sulfate (CS)-rich region that accounts for more than 80% of the molecular mass. The very C-terminal end contains a number of distinct domains including one with homology to C-type lectins.

Proteoglycan aggregates are made up of several aggrecan molecules that are bound via their G1 domains to hyaluronan. The binding is stabilized by a third component, the link protein, that binds simultaneously to aggrecan and hyaluronan (see Heinegård and Sommarin, Ref. 5). In the aggregate, the G2 and KS-rich portions are interspaced between the central hyaluronan strand and the region with the densely packed CS chains. The structure of the KS-rich region suggests a relatively extended and rigid conformation. This is supported by electron microscopy of spread proteoglycan aggregates after rotary shadowing, showing that the CS-rich region is clearly separated from the central filament of hyaluronan (6). It appears that the KS-rich region acts as a spacer within the proteoglycan aggregate. Interestingly, the dimensions of this region are similar to the diameter of the collagen fibril.

The primary structure of the KS-rich region polypeptide encompasses a number of consecutive proline-rich hexapeptide repeats, where the bovine form contains 23 of these repeats (4). The proline-rich repeat may form a polyproline coil.2 Such a structure has the potential for interacting with the collagen fibril, which in this case could find sufficient space to run through the center of the proteoglycan aggregate and by interactions reinforce the network of assembled aggrecan molecules. This hypothesis was put to test in the present work.

    EXPERIMENTAL PROCEDURES

Proteoglycan Fragments-- Fragments of bovine nasal cartilage aggrecan were prepared according to previously described procedures (7). The trypsin-resistant fragment KS.t represents the KS-rich region extended to and including parts of the G2 domain (8). A more extensively trimmed fragment, KS.t.c, which was obtained by additional digestion with chymotrypsin, represents exclusively the KS-rich region (7). The tryptic fragment HABr represents the hyaluronan-binding region, whereas the preparation CS-pep contains several peptides derived from the CS-rich region. Intact aggrecan core protein devoid of CS was prepared by digestion with chondroitinase ABC (9).

Purification of Antibodies-- The antibodies against the KS-rich portion of aggrecan were prepared from a polyclonal antiserum raised against the entire bovine aggrecan molecule (10). Two affinity columns containing CNBr-activated Sepharose 4B (Amersham Pharmacia Biotech), to which isolated aggrecan fragments had been coupled, were used for the purification. The antiserum was first passed through a column containing the fragment HABr coupled at 2 mg/ml of gel. The flow-through fraction of the antiserum, thus devoid of unspecifically binding antibodies or antibodies recognizing epitopes within the HABr, was subsequently passed through a column containing gel with coupled KS.t. Bound antibodies were eluted with 3 M potassium isocyanate followed by dialysis against 0.15 M NaCl, 5 mM NaPi, pH 7.4.

Enzyme-linked Immunosorbent Assay-- Specificity of purified antibodies was examined by using an inhibition-type enzyme-linked immunosorbent assay (10). Samples of antibody solution were preincubated with different isolated aggrecan fragments. The incubation mixtures were then transferred to microtiter plates coated with core protein of bovine aggrecan. Antibodies bound to this protein coat were quantified by incubation with a swine anti-rabbit (IgG) alkaline phosphatase conjugate (Orion Chemicals), followed by paranitrophenyl phosphate as a substrate for bound enzyme.

A microplate solid-phase assay was used to measure binding of proteoglycan fragments to immobilized collagen molecules. The assay procedure was similar to that described previously (11), with some modifications as detailed in the following. Microplate wells were coated overnight with pepsin-extracted collagen I at 10 µg/ml or collagen II at 50 µg/ml in 0.14 M NaCl, 30 mM NaPi, pH 7.3 and after that coated for 1 h with kappa -casein at 100 µg/ml to block unspecific interactions. The wells were washed with buffer containing 0.05% Tween 20 and then incubated with ligand solution. Antibodies used for detection of bound ligand were either the affinity purified anti-KS.t antibodies or the monoclonal 5D4 that specifically recognizes KS (12). These primary antibodies were detected with a secondary antibody, the former with a swine anti-rabbit (IgG) alkaline phosphatase conjugate and the latter with a goat anti-mouse (IgG) (Orion Chemicals), and the substrate paranitrophenyl phosphate. Absorbance was measured at 405 nm, and the data were processed as described (11).

Before some of the binding experiments, KS was digested using either endo-beta -galactosidase (Boehringer Mannheim) or keratanase II (Seikagaku Corp.). Samples of KS.t and KS.t.c were digested with approximately 5 milliunits of enzyme/mg of substrate in 0.14 M NaCl, 30 mM NaPi, pH 7.3, for 2 h at 37 °C. Efficiency of digestion was confirmed by SDS-polyacrylamide gel electrophoresis, showing higher migration rates of fragments after enzyme treatment.

In one set of experiments, the binding of KS.t after papain cleavage was examined. An aliquot of a solution containing the proteoglycan fragment was combined with papain (200 µg/mg of proteoglycan) in 10 mM EDTA, 2 mM dithioerythritol, 0.14 M NaCl, 30 mM NaPi, pH 7.3, and digested at 40 °C for 24 h. The enzyme was then inactivated by addition of iodoacetamide to a concentration of 20 mM and heating in a boiling water bath for 5 min. A control sample was prepared from another aliquot of the KS.t solution and some papain solution, treated identically as the digested sample except that the enzyme and the proteoglycan fragment were kept separated until the inactivation procedure had been completed.

Electron Microscopy-- The distribution of the aggrecan KS-rich region in bovine articular cartilage was examined in low temperature-embedded tarsometatarsal (fetlock) joints. Slices comprising the entire cartilage with adjoining subchondral bone, were cut from central areas of the proximal medial metatarsal condyle and processed as described elsewhere (13). In short, fixation was performed in a mixture of 0.3% glutaraldehyde and 0.3% paraformaldehyde and then dehydrated by stepwise increasing concentrations of methanol at temperatures progressively lowered to 228 K. Embedding was performed in Lowicryl K11M (Chemische Werke Lowi GmbH, Waldkraiburg, Germany). Ultrathin (40-50 nm) sections were placed on Formvar-coated nickel grids and preincubated with 10% bovine serum albumin for 2 h, followed by incubation with primary antibody in phosphate-buffered saline containing 0.1% bovine serum albumin. The uncalcified cartilage was stratified into three zones. The zones and the compartments around the cells were those defined previously (14, 15).

Sampling from each of two blocks per animal (n = 5) and measurements were performed as described elsewhere (14, 15). Immunoreactivity was visualized with protein-A conjugated to 10-nm gold probes (Amersham Pharmacia Biotech, UK) in sections contrasted with uranyl acetate and lead citrate.

For assessing the association between collagen fibrils and labeling (n = 3), matrix was divided into two compartments. Fibrillar labeling was defined as gold particles projected over collagen fibrils. Interfibrillar labeling was defined as all that outside the border of the fibril. The number of gold probes was counted, and the collagen volume density (v/v) in the pericellular and territorial compartments of zone II was measured by point counting (16). Immunoreactivity was then correlated to collagen v/v of the pericellular and territorial compartments and a ratio between fibrillar and interfibrillar labeling was calculated for each compartment.

To study the distribution of the aggrecan KS-rich region along the collagen fibrils, bovine tarsometatarsal joint cartilage (n = 3) was prepared for cryosectioning as described elsewhere (15). Ultrathin cryosections (100 nm) were incubated with primary antibodies and immunoreactivity was detected with protein-A-coated 10 nm gold probes. From random high power (× 250,000) electron micrographs, the distribution of gold probes along the fibrils was measured (15).

    RESULTS

Specificity of Antibodies-- Binding of affinity purified antibodies to the aggrecan core protein was measured by enzyme-linked immunosorbent assay. To determine the localization of epitopes within the aggrecan structure, inhibition of binding by different aggrecan fragments was examined (Fig. 1). Neither isolated HABr nor peptides representing the CS-rich region inhibited the binding of antibodies. Two different preparations of fragments containing the KS-rich region strongly inhibited binding. The fragments prepared using trypsin in combination with chymotrypsin inhibited the antibody binding to the same extent as the fragments prepared using trypsin only. Because the fragments remaining after chymotrypsin digestion essentially represent the KS-rich region proper, i.e. the hexapeptide repeat structure with the KS chains, the antibodies used here mainly recognize epitopes within this region.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Specificity of antibodies toward the keratan sulfate-rich region of aggrecan. Affinity purified antibodies were incubated in microplate wells coated with aggrecan core protein. Inhibition of antibody binding was tested by preincubation of the antibodies with enzymatically generated cleavage products of aggrecan, i.e. peptides representing the chondroitin sulfate-rich region (CS pep.), the hyaluronan-binding region (HABr), the entire core protein (Core), a fragment containing the keratan sulfate-rich region and parts of the second globular domain (KS.t), and a somewhat smaller fragment corresponding essentially to the keratan sulfate-rich portion only (KS.t.c). Bound antibodies were detected by a swine anti-rabbit (IgG) alkaline phosphatase conjugate and paranitrophenyl phosphate as a substrate for bound enzyme.

Binding of Aggrecan KS-rich Fragments to Collagens in Vitro-- As discussed above, the KS-rich region has a structure indicative of a potential for binding to collagen. To examine this possibility, we studied binding of the isolated domain to collagen in vitro. A microplate solid-phase binding assay was used. The fragment KS.t, which contains the KS-rich region and the polypeptide up to and in some fragments actually including parts of the second globular domain, showed saturable binding to collagen I as well as collagen II (Fig. 2, top). The amounts of KS.t bound at saturation were larger for wells with collagen I than for wells with collagen II, probably reflecting differences in the amounts of immobilized collagen. In a Scatchard-type plot, the data displayed linear correlations, indicating that the binding sites were homogeneous (Fig. 2, bottom). The affinity of the KS.t fragment was the same for collagen I and collagen II, with an apparent dissociation constant of 1.1 µM. This represents a fairly weak interaction. For comparison, the affinities shown by the small proteoglycans decorin and fibromodulin in the same type of assay were about 100 times higher (11).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Binding of an aggrecan fragment (KS.t) containing the keratan sulfate-rich region and parts of the second globular domain, to isolated collagens in vitro. Microplate wells were coated with collagen I (), collagen II (open circle ), or kappa -casein only (), followed by incubation with samples of KS.t at concentrations from 0 to 256 µg/ml. Bound KS.t was determined by enzyme-linked immunosorbent assay using affinity purified antibodies as in Fig. 1. Conversion of the substrate to colored product was measured as increase of absorbance at 405 nm (top). Specific absorbance changes (Delta A) were calculated by subtraction of the absorbance values for control wells coated with kappa -casein. These data were used for a Scatchard-type plot (bottom), assuming a molecular mass of the KS.t fragment of 160 kDa (7). The dissociation constants, calculated from the slopes of the fitted lines, were 1.1 µM both with collagen I and collagen II.

Binding of the fragment KS.t.c, apparently representing the repeat polypeptide with the KS-chains only (7), to collagen I was not different from that of KS.t (Fig. 3). Hence, the peptide portions adjacent to the repeat defining the true KS-rich region did not contribute significantly to the collagen interactions. Moreover, the fragments still had capacity to bind to collagen after enzymatic hydrolysis of the KS (Fig. 3) using either keratanase II or endo-beta -galactosidase. However, the binding capacity was dramatically reduced if the KS.t core protein was extensively cleaved by digestion with papain (Fig. 4). These observations support the view that the interaction depends on the core protein.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Binding of aggrecan fragments to isolated collagen I in vitro. Microplate wells, coated with collagen I, were incubated with samples of aggrecan fragments KS.t or KS.t.c at either 5 µg/ml or 50 µg/ml. In some cases, KS was digested with keratanase II (k'ase). Some wells served as negative controls and were incubated with buffer only. Affinity purified antibodies were used for detection as in Fig. 1.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Binding to collagen I in vitro of aggrecan fragments derived from the KS-rich region. Microplate wells, coated with collagen I (black-square, ), or kappa -casein only(, open circle ), were incubated with samples of KS.t fragments that had been pre-treated with active papain (, open circle ). Alternatively, the KS.t samples contained papain that already was inactivated when added to the proteoglycan fragments (black-square, ). Bound fragments were detected by enzyme-linked immunosorbent assay with KS-specific monoclonal antibodies and a goat anti-mouse (IgG) alkaline phosphatase conjugate. Conversion of the substrate paranitrophenyl phosphate to colored product was measured as increase of absorbance at 405 nm.

To further characterize the collagen interaction of the KS.t fragment, the sensitivity to increased ionic strength was examined. Binding was not affected by small differences in salt concentration within the near-physiological range, but it was gradually decreased at NaCl concentrations higher than 0.15 M (Fig. 5). This suggests that charged groups are important for the interaction. The primary structure of the KS.t core protein consists of repeated hexapeptide units, typically with the sequence Glu-Xaa-Pro-Phe-Pro-Ser (4). Glutamic acid residues occupy the first position in 22 of the 23 units and, in addition, the second position in 11 of the units. Therefore, it is likely that the negative charges of the glutamates have a role in the interaction. Still, the observation that significant binding occurred at the relatively high NaCl-concentrations of 0.5-0.6 M (Fig. 5) suggests that other forces in addition to pure electrostatic attraction are involved in this protein-protein interaction.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 5.   Binding of the aggrecan KS.t fragment to collagen I in vitro at different concentrations of NaCl. Microplate wells were coated with collagen I () or kappa -casein only (open circle ) and were then washed with 30 mM phosphate buffer containing 1 M NaCl and with buffer containing 0.1 M NaCl. Next, the wells were incubated with samples of KS.t at 50 µg/ml in phosphate buffer containing NaCl at concentrations ranging from 0.1 to 0.6 M. Unbound KS.t was removed by washing the wells four times with solvent of unchanged composition, followed by washing of all wells with buffer containing 0.1 M NaCl. Bound KS.t was detected by enzyme-linked immunosorbent assay, which was done similarly as in Fig. 4 except that a solvent buffer containing 0.1 M NaCl was used.

Ultrastructural Immunolocalization of the Aggrecan KS-rich Region-- Electron microscopy of bovine articular cartilage after immunogold-labeling with the antibodies, showed that reactivity was lowest in the superficial part and about two times higher in the middle and deep parts (Table I). Labeling of the interterritorial matrix was slightly lower than that for the matrix closer to the cells. Because it is likely that all aggrecan molecules retained in the matrix will contain the KS-rich region, regardless of partial fragmentation, the distribution of the KS.t immunoreactivity can be taken as a measure of aggrecan distribution. The results corroborate and extend those obtained by other techniques (17-19).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Immunoreactivity of aggrecan keratan-sulfate-rich region in uncalcified bovine articular cartilage
Zone I is the superficial part; zone II is the upper part of the radial zone; and zone III is the lowermost part of the radial zone. Resin-embedded sections; mean (S.D.) (n = 5); *, denotes significant difference between zone I and II; #, denotes significant difference between zone I and III. p < 0.05.

Immunoreactivity for the aggrecan KS-rich region was preferentially localized within the proximity of collagen fibrils. Thus, fibrillar labeling was about 2-4 times higher than interfibrillar labeling in the pericellular and territorial compartments (Table II). Only probes projected on a collagen fibril or tangent to the border of the fibril were counted as fibril-associated (Fig. 6). This should represent an underestimation of the true fibrillar labeling because the dimensions of the immunogold complex allow a proportion of the gold particles attached to targets on the collagen fibril to be projected outside the fibril. The expected diameter of the complex is about 23 nm (20), and consequently a major proportion of the probes within this distance from the fibril surface may reflect the fibril-associated KS-rich region. However, we refrained from regarding any probes not touching the fibrils as associated because this would have imposed difficulties in defining the interfibrillar matrix. Unfortunately, it was still not possible to distinguish between fibrillar and interfibrillar labeling on micrographs showing interterritorial matrix. This was because of the high volume density of fibrils and concomitant overprojection of gold particles.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Correlation of aggrecan keratan sulfate-rich region to collagen fibrils in the pericellular and territorial compartments of zone II in bovine articular cartilage
Resin-embedded sections; mean (S.D.) (n = 3).


View larger version (191K):
[in this window]
[in a new window]
 
Fig. 6.   Electron microscopic immunolocalization of the aggrecan keratan sulfate-rich region in bovine articular cartilage. The micrograph was taken from the pericellular area within the superficial zone of the articular cartilage, and it shows collagen fibrils together with colloidal gold probes for immunoreactivity. Probes projected over the fibrils or tangent to the border of the fibrils (fibrillar labeling) were counted as collagen-associated (open arrows), whereas probes projected outside the border (interfibrillar matrix) were counted as nonassociated (solid arrows). Resin-embedded section, magnification × 95,000.

The distribution of gold probes along the individual fibril was assessed with cryosections at high power magnification. Cryosections were preferred because they give a higher intensity of labeling than that obtained with sections of resin-embedded tissue. In this case, immunolabeling with antibodies against the KS-rich region displayed a non-random distribution along the fibril axis. Labeling showed a marked preference to the gap region within the D-period (Fig. 7). A more precise identification of the localization within the gap region is not feasible with the present technique because of limitations imposed by the size of the immunogold complex, which represents about one-third of the length of the D-period (20).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Histogram showing the distribution of aggrecan keratan sulfate-rich region immunoreactivity in relation to a collagen fibril in bovine articular cartilage. Measurements were performed on high-power micrographs from cryosectioned cartilage. To delineate the distribution, the first thin band of one D-period was identified, and the distance to each probe was measured. Note the non-random distribution within the D-period, with preference to the gap region (dark field). n = 123.


    DISCUSSION

Previous histochemical studies have indicated a close spatial relationship between proteoglycans and collagen in soft tissues, e.g. in tendon and annulus fibrosus (21) and in articular cartilage (22). Immunohistochemical examination has shown that the small dermatan sulfate proteoglycan decorin is associated with fibrils in tendon (23) and dermis (24), apparently because of interactions between the core protein and collagen. In cartilage, both decorin and collagen IX occur as fibril-associated proteoglycans (25, 26), albeit that most of the collagen IX molecules in mammalian cartilage do not appear to have an attached glycosaminoglycan chain (27). Furthermore, we have observed that the keratan sulfate proteoglycan fibromodulin is distributed along collagen fibrils in articular cartilage (15), also apparently bound via its core protein (11, 28). These small proteoglycans are bound to the fibrils by strong interactions, in the case of collagen IX stabilized by covalent bonds. Therefore, these molecules can be considered as fibril constituents. In contrast, the large cartilage proteoglycan aggrecan occurs in the tissue in a well characterized supramolecular form that is distinct from the fibrils. This aggregate consists of up to 100 aggrecan monomers and an equal number of link proteins, associated with a single strand of hyaluronan. It is likely that there are interactions between collagen fibrils and the proteoglycan aggregates, important for the mechanical properties of cartilage, but the mechanisms are not known. Based on work with in vitro systems, it has been proposed that the CS-rich region of aggrecan is essential for interactions (29, 30). The existence of an interaction of some kind within the tissue, is supported by observations made by immunoperoxidase electron microscopy indicating a periodic arrangement of the proteoglycan along cartilage fibrils (31).

The results presented here provide strong evidence that a proteoglycan aggregate interacts with a collagen fibril located within the aggregate, near the central hyaluronan strand. It is reasonable to assume that the KS-rich region represents an extended structure surrounded by free space. This molecular architecture may allow diffusion of some matrix constituents, e.g. procollagen, and may participate in specific interactions. Hypothetically, a collagen fibril may be positioned as a backbone within the aggrecan complex and connect several aggrecan KS-rich regions (Fig. 8). Even though each KS-rich region forms a fairly weak interaction, the multiplicity existing in the aggregate would result in a very tight complex with the collagen fibril. Such an arrangement would considerably influence the structural integrity of the proteoglycan aggregate. It could also have an important role in providing the microenvironment for the formation of fibrils in cartilage.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 8.   Schematic illustration of a hypothetical interaction between a cartilage collagen fibril and aggrecan monomers via the keratan sulfate-rich region. Because of multiple interactions with the proteoglycan aggregate, the fibril may serve as a backbone to the aggrecan complex.


    FOOTNOTES

* This study was supported by grants from the Swedish Medical Research Council, the Swedish Medical Association (12231-020A), the Swedish Association against Rheumatism, Inga Britt and Arne Lundberg's Research Foundation, Axel and Margaret Ax:son Johnson's Foundation, Loo and Hans Osterman's Foundation, Anna-Greta Crafoord's Foundation, King Gustaf V's 80 year Anniversary Foundation, Signe and Reinhold Sund's Foundation for Rheumatologic Research, Ulla and Gustaf af Ugglas' Foundation, the Bank of Sweden Tercentenary Foundation, Clas Groschinky's Foundation, Ragnhild and Einar Lundström's Memorial Foundation, Sigurd and Elsa Golje's Memorial Foundation, Alfred Österlund's Foundation, Greta and Johan Kock's Foundations, Gunand Bertil Stohne's Foundation and from Karolinska Institutet, Stockholm.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Orthopedics, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Huddinge, Sweden. Tel.: 46 8 585 80000; Fax: 46 8 711 4292; E-mail: Hakan.Hedlund{at}karo.ki.se.

2 Jürgen Engel, personal communication.

    ABBREVIATIONS

The abbreviations used are: KS, keratan sulfate; HABr, hyaluronan-binding region; G1, first globular domain of aggrecan; G2, second globular domain of aggrecan; CS, chondroitin sulfate.

    REFERENCES
Top
Abstract
Introduction
References
  1. Hukins, D. W. L., and Aspden, R. M. (1985) Trends Biochem. Sci. July, 260-265
  2. Heinegård, D., and Oldberg, Å. (1993) in Connective Tissue and Its Heritable Disorders (Royce, P. M., and Steinmann, B., eds), pp. 189-209, Wiley-Liss Inc., New York
  3. Maroudas, A. (1976) Nature 260, 808-809[Medline] [Order article via Infotrieve]
  4. Antonsson, P., Heinegård, D., and Oldberg, Å. (1989) J. Biol. Chem. 264, 16170-16173[Abstract/Free Full Text]
  5. Heinegård, D., and Sommarin, Y. (1987) in Methods in Enzymology, Structural and Contractile Proteins (Cunningham, L. W., ed), Vol. 144, pp. 305-319, Academic Press Inc., New York
  6. Heinegård, D., Lohmander, S., and Thyberg, J. (1978) Biochem. J. 175, 913-919[Medline] [Order article via Infotrieve]
  7. Heinegård, D., and Axelsson, I. (1977) J. Biol. Chem. 252, 1971-1979[Abstract]
  8. Wiedemann, H., Paulsson, M., Timpl, R., Engel, J., and Heinegård, D. (1984) Biochem. J. 224, 331-333[Medline] [Order article via Infotrieve]
  9. Hascall, V. C., and Heinegård, D. (1974) J. Biol. Chem. 249, 4242-4249[Abstract/Free Full Text]
  10. Wieslander, J., and Heinegård, D. (1979) Biochem. J. 179, 35-45[Medline] [Order article via Infotrieve]
  11. Hedbom, E., and Heinegård, D. (1989) J. Biol. Chem. 264, 6898-6905[Abstract/Free Full Text]
  12. Caterson, B., Christner, J. E., and Baker, J. R. (1983) J. Biol. Chem. 258, 8848-8854[Abstract/Free Full Text]
  13. Hultenby, K., Reinholt, F. P., Oldberg, Å., and Heinegård, D. (1991) Matrix 11, 206-213[Medline] [Order article via Infotrieve]
  14. Hedlund, H., Mengarelli-Widholm, S., Reinholt, F. P., and Svensson, O. (1993) APMIS 101, 133-140[Medline] [Order article via Infotrieve]
  15. Hedlund, H., Mengarelli-Widholm, S., Heinegård, D., Reinholt, F. P., and Svensson, O. (1994) Matrix Biol. 14, 227-232[CrossRef][Medline] [Order article via Infotrieve]
  16. Weibel, E. R. (1979) Stereological Methods, Vol. 1, Academic Press, New York
  17. Stockwell, R. A., and Scott, J. E. (1967) Nature 215, 1376-1378[Medline] [Order article via Infotrieve]
  18. Lemperg, R., Larsson, S-E., and Hjertquist, S-O. (1974) Calcif. Tissue Res. 15, 237-251[Medline] [Order article via Infotrieve]
  19. Franzén, A., Inerot, S., Hejderup, S-O., and Heinegård, D. (1981) Biochem. J. 195, 535-543[Medline] [Order article via Infotrieve]
  20. Griffiths, G. (1993) in Fine Structure Immunocytochemistry (Griffiths, G., ed), pp. 237-278, Springer-Verlag, New York
  21. Scott, J. E. (1991) Int. J. Biol. Macromol. 13, 157-161[CrossRef][Medline] [Order article via Infotrieve]
  22. Orford, C. R., and Gardner, D. L. (1984) Connect. Tissue Res. 12, 345-348[Medline] [Order article via Infotrieve]
  23. Pringle, G. A., and Dodd, C. M. (1990) J. Histochem. Cytochem. 38, 1405-1411[Abstract]
  24. Fleischmajer, R., Fisher, L. W., MacDonald, E. D., Jacobs, L., Jr., Perlish, J. S., and Termine, J. D. (1991) J. Struct. Biol. 106, 82-90[Medline] [Order article via Infotrieve]
  25. Vaughan, L., Mendler, M., Huber, S., Bruckner, P., Winterhalter, K. H., Irwin, M. I., and Mayne, R. (1988) J. Cell Biol. 106, 991-997[Abstract]
  26. Hagg, R., Bruckner, P., and Hedbom E.(1998) J. Cell Biol., in press
  27. Ayad, S., Marriot, A., Brierley, V. H., and Grant, M. E. (1991) Biochem. J. 278, 441-445[Medline] [Order article via Infotrieve]
  28. Hedbom, E., and Heinegård, D. (1993) J. Biol. Chem. 268, 27307-27312[Abstract/Free Full Text]
  29. Oegema, T. R., Jr., Laidlaw, J., Hascall, V. C., and Dziewiatkowski, D. D. (1975) Arch. Biochem. Biophys. 170, 698-709[Medline] [Order article via Infotrieve]
  30. Toole, B. P. (1976) J. Biol. Chem. 251, 895-897[Abstract]
  31. Poole, A. R., Pidoux, I., Reiner, A., and Rosenberg, L. (1982) J. Cell Biol. 93, 921-937[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.